Aug. 07, 2026
LAKE FOREST, CALIFORNIA — Sonorous Neurovascular has enrolled the first Canadian patient in its international B-SILENT clinical study evaluating the investigational BosSTENT™ for the treatment of debilitating pulsatile tinnitus associated with symptomatic cerebral venous sinus stenosis. The enrollment took place at The Ottawa Hospital under principal investigator Dr. Robert Fahed and marks the study’s expansion into Canada. The B-SILENT study
















